- Home
- AEF vs SOPH Comparison
AEF vs SOPH Comparison
Compare AEF & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEF
- SOPH
- Stock Information
- Founded
- AEF 1989
- SOPH 2011
- Country
- AEF United States
- SOPH Switzerland
- Employees
- AEF N/A
- SOPH N/A
- Industry
- AEF Finance/Investors Services
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AEF Finance
- SOPH Health Care
- Exchange
- AEF Nasdaq
- SOPH Nasdaq
- Market Cap
- AEF 237.8M
- SOPH 206.6M
- IPO Year
- AEF N/A
- SOPH 2021
- Fundamental
- Price
- AEF $4.84
- SOPH $2.83
- Analyst Decision
- AEF
- SOPH Strong Buy
- Analyst Count
- AEF 0
- SOPH 2
- Target Price
- AEF N/A
- SOPH $6.50
- AVG Volume (30 Days)
- AEF 92.5K
- SOPH 36.0K
- Earning Date
- AEF 01-01-0001
- SOPH 05-06-2025
- Dividend Yield
- AEF 7.13%
- SOPH N/A
- EPS Growth
- AEF N/A
- SOPH N/A
- EPS
- AEF 0.57
- SOPH N/A
- Revenue
- AEF N/A
- SOPH $65,173,000.00
- Revenue This Year
- AEF N/A
- SOPH $14.83
- Revenue Next Year
- AEF N/A
- SOPH $22.79
- P/E Ratio
- AEF $8.86
- SOPH N/A
- Revenue Growth
- AEF N/A
- SOPH 4.49
- 52 Week Low
- AEF $4.40
- SOPH $2.60
- 52 Week High
- AEF $5.53
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- AEF 46.04
- SOPH 42.78
- Support Level
- AEF $4.80
- SOPH $2.60
- Resistance Level
- AEF $4.78
- SOPH $3.00
- Average True Range (ATR)
- AEF 0.15
- SOPH 0.32
- MACD
- AEF 0.02
- SOPH -0.00
- Stochastic Oscillator
- AEF 65.08
- SOPH 25.84
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. It invests in the public equity and fixed income markets of Chile. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, Private Equity, telecommunication services, healthcare, real estate and industrials.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.